Ramsay, Stattman, Vela & Price, Inc. Abbott Laboratories Transaction History
Ramsay, Stattman, Vela & Price, Inc.
- $510 Million
- Q1 2025
A detailed history of Ramsay, Stattman, Vela & Price, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ramsay, Stattman, Vela & Price, Inc. holds 112,016 shares of ABT stock, worth $14.2 Million. This represents 2.92% of its overall portfolio holdings.
Number of Shares
112,016
Previous 111,095
0.83%
Holding current value
$14.2 Million
Previous $12.6 Million
18.25%
% of portfolio
2.92%
Previous 2.4%
Shares
32 transactions
Others Institutions Holding ABT
# of Institutions
3,572Shares Held
1.37BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$21.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.83 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.46 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.42 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $222B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...